Description
This guidance supersedes “Guidance for Industry and FDA Staff Dental Composites -Premarket Notification” issued November 27, 1998
Key Topics
Terms and concepts identified from this document
Scope & Applicability
Product Classes
7Subject of the premarket notification guidance; Subject of the 510(k) review requirements; Device requiring barrier features and specifications in critical areas; Medical device subject to 510(k) submission
product with multiple components like vials and packets
Subject of the premarket notification guidance
Subject of the premarket notification guidance; Subject of the 510(k) review requirements; Device requiring sterility assurance level of 10-6; Medical device subject to 510(k) submission
Premarket notification requirements for device kits
Drawings should show barrier features and specifications in critical areas
Must be an effective barrier for minimizing the passage of microorganisms
Stakeholders
4Entities submitting data to FDA for device clearance
Entity submitting development data and knowledge; Entity performing the work process for change
Entity providing guidance documents upon request
Entity responsible for submitting NDINs
Regulatory Context
Regulatory Activities
1Premarket notification submission type
Document Types
4Required information for the device submission
document for Thoratec HeartMate II
Required component of the QMS information in a submission
Reference for sterility information requirements
Attributes
3Evidence of a new intended use based on communications
Quality parameter that must remain unchanged for the policy
Required level for surgical drapes and gowns
Technical Details
Substances
5Contaminant (EG) that causes fatal poisonings.; High-risk drug component contaminant associated with fatalities.; testing of drug components for contamination
Products being evaluated in master protocols.
Included under the scope of investigational drugs for disqualification purposes.
sterilization facilities that use a gas called ethylene oxide (EtO) to sterilize medical devices; Common method of terminal sterilization of medical devices; sterilization facility change involving EtO; Sterilant used in the manufacturing process
Residue to be measured following EtO sterilization; state the level of residue in parts per million
Processes
2Required information regarding the sterile state of the device
Required for contaminated equipment and media before disposal
Identified Hazards
Hazards
3Risk that surgical apparel is intended to protect against.; Risk that surgical apparel is intended to prevent.
Transfer during surgical procedures
risk in multidose drug products
Standards & References
External Standards
10Flammability testing standard
Association for the Advancement of Medical Instrumentation
Standard Test Method for Resistance of Protective Clothing Materials to Synthetic Blood; Barrier performance test standard
Test Method for Resistance of Protective Clothing Materials to Penetration by Bloodborne Pathogens; Barrier performance test standard
National Fire Protection Association standards for inhalation anesthetics
Water Resistance: Hydrostatic Pressure
Colorfastness to Laundering, Home and Commercial: Accelerated
Elemendorf Tear test; Strength testing standard
Grab Tensile/Elongation test; Strength testing standard
Standard method for validating sterilization cycles
Specifications
3Required technical details in the device description section
Feature to be compared between new device and predicate
physical characteristic measured before and after aging
Related CFR Sections (4)
- 21CFR862.9§ 862.9 Limitations of exemptions from section 510(k) of the Federal Food, Drug, and Cosmetic Act (the act).
The exemption from the requirement of premarket notification (section 510(k) of the act) for a generic type of class I or II device is only to the extent that the device has existing or reasonably foreseeable characteristics of commercially distributed devices within that generic type or, in the casRead full regulation →
- 21CFR878.4040§ 878.4040 Surgical apparel.
(a) Identification. Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgicalRead full regulation →
- 21CFR878.4370§ 878.4370 Surgical drape and drape accessories.
(a) Identification. A surgical drape and drape accessories is a device made of natural or synthetic materials intended to be used as a protective patient covering, such as to isolate a site of surgical incision from microbial and other contamination. The device includes a plastic wound protector thaRead full regulation →
- 21CFR807.87§ 807.87 Information required in a premarket notification submission.
Each premarket notification submission shall contain the following information:Read full regulation →
Enforcement Impact
Deficiencies cited in Warning Letters referencing the same regulations
Related Warning Letters (2)
Related MFDS Guidelines
Korean regulatory guidelines covering similar topics
See Also (8)
- The Least Burdensome Provisions: Concept and Principles: Guidance for Industry and FDA Staff (Status: Final)
- CPG Sec. 398.450 Applicability of Positive Beam Limitation (PBL) Requirements When PBL is Provided on "Other than Stationary General Purpose" Radiographic System (Status: Final)
- Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators (Status: Final)
- CPG Sec. 398.300 Registration of Assemblers of Diagnostic X-Ray Systems as Device Manufacturers (Status: Final)
- CPG Sec. 391.200 Warning Statement in Advertisements for High-Intensity Mercury Vapor Discharge Lamps that are not Self-Extinguishing (21 CFR 1040.30(e)(3)*) (Status: Final)
- CPG Sec. 390.425 Records and Reports; Applicability - 21 CFR 1002.1 (Status: Final)
- Testing Guidance for Male Condoms Made From New Material (Non-Latex) (Status: Final)
- Addendum to: Guidance on Premarket Notification [510(k)] Submissions for Sterilizers Intended for Use in Health Care Facilities (Status: Final)